New

South and Central America Hypertrophic and Keloid Scar Treatment Market

2021

South and Central America Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)

Publication Month: Oct 2021 | Report Code: TIPRE00025200 | No. of Pages: 88 | Category: Medical Device | Status: Published

Market Insights

South and Central America Hypertrophic and Keloid Scar Treatment Market to Grow at a CAGR of 9.8% to reach US$ 477.69 million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The hypertrophic and keloid scar treatment market in South and Central America is expected to grow from US$ 248.42 million in 2020 to US$ 477.69 million by 2027; it is estimated to grow at a CAGR of 9.8% from 2020 to 2027.


Brazil and Argentina are major economies in South and Central America. Emerging treatments modalities is the major factor driving the growth of the South and Central America hypertrophic and keloid scar treatment market. At present, there are various treatments available to treat hypertrophic and keloid scars. The emerging treatments are based on stem cell therapy, verapamil, mitomycin C (MMC), interferons, bleomycin, ACE inhibitors, and botulinum toxin type A. Most of these treatments have shown promising results. On the other hand, the topical products are being used to reduce the thickness of scars and lighten them as they are esthetically unpleasing. However, laser treatment and radiotherapy are associated with side effects, and they do not heal the scars completely. Therefore, researchers are continuously studying these treatments and are yet to derive a standard treatment for hypertrophic and keloid scars. Likewise, manufacturers are also engaged in developing products such as extracellular-matrix that control the proliferation of collagen, thereby preventing the excess deposition of the same. Keloid scars can also be related to genetic factors; hence, they are considered major clinical challenges. Therefore, the ongoing research and developments are likely to provide preventive measures and extraordinary treatments for hypertrophic and keloid scars treatment during the forecast period, which is further anticipated to drive the market in South and Central America.

South and Central America has witnessed a growing number of cases of COVID-19 since its outbreak. For example, according to the Worldometer, the number of cases reached 13,382,026, with 366,256 recorded deaths in South America as of January 2021. In Brazil, the first case of COVID-19 was confirmed on February 26, 2020, and now, the cases have reached 7,754,560, with 196,591 deaths. Argentina and Colombia reached 1,648,940 and 1,686,131 cases of COVID-19 as of January 2021. COVID-19 is predicted to result in the region's worst recession, causing the region's GDP to contract by 9.1% in 2020. This is projected to increase the number of poor by 45 million and the highly poor by 28 million. The COVID‐19 pandemic is a vital test for the still overburdened and underfunded public health systems of South and Central America. Moreover, it will decrease imports due to disruptions in global trade, further increasing the scarcity of medical supplies and other goods, resulting in a significant price increase.

Get more information on this report :


South and Central America Hypertrophic and Keloid Scar Treatment Market Segmentation

South and Central America Hypertrophic and Keloid Scar Treatment Market – By Scar Type

  • Hypertrophic
  • Keloid

South and Central America Hypertrophic and Keloid Scar Treatment Market – By Product Type

  • Injectables
  • Topical
    • Gels
    • Silicone Sheets
    • Creams
    • Other
  • Laser
    • CO2
    • Pulse-Dyed
    • Other
  • Other

South and Central America Hypertrophic and Keloid Scar Treatment Market – By End User

  • Hospitals
  • Clinics
  • Homecare

South and Central America Hypertrophic and Keloid Scar Treatment Market, by Country

  • Brazil
  • Argentina
  • Rest of South & Central America

South and Central America Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned

  • Alliance Pharma PLC
  • HRA Pharma
  • Mölnlycke Health Care AB.
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc
  • Suneva Medical

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South and Central America Hypertrophic and Keloid Scar Treatment Market – By Scar Type

1.3.2 South and Central America Hypertrophic and Keloid Scar Treatment Market – By Product Type

1.3.3 South and Central America Hypertrophic and Keloid Scar Treatment Market – By End User

1.3.4 South and Central America Hypertrophic and Keloid Scar Treatment Market – By Country

2. South and Central America Hypertrophic and Keloid Scar Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South and Central America Hypertrophic and Keloid Scar Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South & Central America– PEST Analysis

4.3 Expert Opinion

5. South and Central America Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Advantages of Laser Treatment

5.1.2 Escalating Cases of Injuries

5.2 Market Restraints

5.2.1 Unavailability of Universal Treatment Due to High Costs, Side Effects, and Scanty Awareness

5.3 Market Opportunities

5.3.1 Tapping Market in Emerging Countries

5.4 Future Trends

5.4.1 Emerging Treatments Modalities

5.5 Impact Analysis

6. Hypertrophic and Keloid Scar Treatment Market – South and Central America Analysis

6.1 South and Central America Hypertrophic and Keloid Scar Treatment Market Revenue Forecast And Analysis

7. South and Central America Hypertrophic and Keloid Scar Treatment Market– By Scar Type

7.1 Overview

7.2 South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

7.3 Hypertrophic

7.3.1 Overview

7.3.2 Hypertrophic: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

7.4 Keloid

7.4.1 Overview

7.4.2 Keloid: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8. South and Central America Hypertrophic and Keloid Scar Treatment Market– By Product Type

8.1 Overview

8.2 South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

8.3 Laser Products

8.3.1 Overview

8.3.2 Laser Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.1 CO2 Market

8.3.2.1.1 Overview

8.3.2.1.2 CO2 Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.2 Pulse-Dyed Market

8.3.2.2.1 Overview

8.3.2.2.2 Pulse-Dyed Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.3 Other Laser Products Market

8.3.2.3.1 Overview

8.3.2.3.2 Other Laser Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4 Topical Products

8.4.1 Overview

8.4.2 Topical Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.1 Creams Market

8.4.2.1.1 Overview

8.4.2.1.2 Creams: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.2 Gels Market

8.4.2.2.1 Overview

8.4.2.2.2 Gels: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.3 Silicone Sheets Market

8.4.2.3.1 Overview

8.4.2.3.2 Silicone Sheets: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.4 Other Topical Products Market

8.4.2.4.1 Overview

8.4.2.4.2 Others Topical Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.5 Injectables

8.5.1 Overview

8.5.2 Injectables: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.6 Other Products

8.6.1 Overview

8.6.2 Other Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9. South and Central America Hypertrophic and Keloid Scar Treatment Market– By End User

9.1 Overview

9.2 South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

10. South and Central America Hypertrophic and Keloid Scar Treatment Market – Country Analysis

10.1 South and Central America: Hypertrophic and Keloid Scar Treatment Market

10.1.1 Overview

10.1.2 South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

10.1.3 Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1 Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2 Brazil: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.3.3 Brazil: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.3.3.1 Brazil: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.3.3.2 Brazil: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.3.4 Brazil: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.4 Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1 Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2 Argentina: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.4.3 Argentina: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.4.3.1 Argentina: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.4.3.2 Argentina: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.4.4 Argentina: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.5 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.5.3 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.5.3.1 Rest of South and Central America: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.5.3.2 Rest of South and Central America: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.5.4 Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

11. Impact Of COVID-19 Pandemic On South and Central America Hypertrophic and Keloid Scar Treatment Market

11.1 South and Central America: Impact Assessment of COVID-19 Pandemic

12. South and Central America Hypertrophic and Keloid Scar Treatment Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Alliance Pharma PLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Mölnlycke Health Care AB.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Smith & Nephew

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Newmedical Technology Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Sonoma Pharmaceuticals, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Suneva Medical

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 HRA Pharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Perrigo Company plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. South and Central America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Table 2. Brazil: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 3. Brazil: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4. Brazil: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. Brazil: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6. Brazil: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. Argentina: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Argentina: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Argentina: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10. Argentina: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Argentina: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 13. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Rest of South and Central America: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15. Rest of South and Central America: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17. Organic Developments Done By Companies

Table 18. Inorganic Developments Done By Companies

Table 19. Glossary of Terms, Hypertrophic and Keloid Scar Treatment Market

LIST OF FIGURES

Figure 1. South and Central America Hypertrophic and Keloid Scar Treatment Market Segmentation

Figure 2. South and Central America Hypertrophic and Keloid Scar Treatment Market, By Country

Figure 3. South and Central America Hypertrophic and Keloid Scar Treatment Market Overview

Figure 4. Hypertrophic Segment Held Largest Share of Scar Type Segment in South and Central America Hypertrophic and Keloid Scar Treatment Market

Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. South & Central America PEST Analysis

Figure 7. Expert Opinion

Figure 8. South and Central America Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint

Figure 9. South and Central America Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast And Analysis – 2019- 2027

Figure 10. South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

Figure 11. Hypertrophic: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 12. Keloid: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 13. South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

Figure 14. Laser Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 15. CO2 Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 16. Pulse-Dyed Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 17. Other Laser Products Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 18. Topical Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 19. Creams Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 20. Gels Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 21. Silicone Sheets Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 22. Other Topical Products Market: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 23. Injectables: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 24. Other Products: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 25. South and Central America Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 26. Hospitals: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 27. Clinics: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 28. Homecare: South and Central America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 29. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 30. South and Central America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

Figure 31. Brazil: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Argentina: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. Rest of South and Central America: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Impact Of COVID-19 Pandemic in South and Central America Market

  1. Alliance Pharma PLC
  2. HRA Pharma
  3. Mölnlycke Health Care AB.
  4. Newmedical Technology Inc.
  5. Perrigo Company plc
  6. Smith & Nephew
  7. Sonoma Pharmaceuticals, Inc
  8. Suneva Medical
  • To understand the South and Central America hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America hypertrophic and keloid scar treatment market
  • Efficiently plan M&A and partnership deals in South and Central America hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America hypertrophic and keloid scar treatment market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in South and Central America region.
TIPRE00025200
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.